Dr Javid Abdelmoneim travels to Japan, Switzerland and Ethiopia to explore how big pharmaceuticals are being mobilised in an unprecedented global initiative to find and fast-track a cure for kala-azar (visceral leishmaniasis). The Cure visits kala-azar patients in Ethiopia, DNDi‘s offices in Geneva, and DNDi partner Eisai in Japan to see how the NTD Drug Discovery Booster hopes to find a cure for kala-azar more quickly.
Watch the video
